About
Adam S. Grossman is a co-founder of ADMA Biologics and has served as President and Chief Executive Officer since October 2011, after serving as President and Chief Operating Officer from 2007 to 2011; he has been a director since 2007. He has more than 30 years of experience in the blood and plasma industry, having previously been Executive Vice President of National Hospital Specialties and GenesisBPS from 1994 to 2011 and worked earlier at MedImmune and the American Red Cross. Since September 2023 he has chaired the North America Board of Directors of the Plasma Protein Therapeutics Association, and he is the son of co-founder Dr. Jerrold B. Grossman.
Roles
Adma Biologics, Inc.
Founder, President, Chief Executive Officer and Director · Current role
2007–present
ADMA Biologics
President and Chief Operating Officer · Served as President and COO before becoming President and CEO in October 2011.
2007-2011
National Hospital Specialties and GenesisBPS
Executive Vice President · Held EVP roles across both companies prior to founding ADMA.
1994-2011
MedImmune, Inc.
Marketing · Worked on marketing teams for RSV and CMV immunoglobulins.
—
American Red Cross
Biomedical Services · Launched new products within the Biomedical Services division.
—
External Roles
Plasma Protein Therapeutics Association (PPTA)
Chair, North America Board of Directors
—
Fixed Compensation
FY 2025
All other compensation
$56,084
Performance Compensation
Data from FY 2025
Cash incentive
Non-equity incentive plan (annual bonus)
$1,156,250
Stock awards
Stock awards (RSUs)
$4,049,994
Also at Adma Biologics, Inc.